777 related articles for article (PubMed ID: 9834103)
21. Leishmania major: targeting IL-4 in successful immunomodulation of murine infection.
Wakil AE; Wang ZE; Locksley RM
Exp Parasitol; 1996 Nov; 84(2):214-22. PubMed ID: 8932771
[TBL] [Abstract][Full Text] [Related]
22. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
23. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
[TBL] [Abstract][Full Text] [Related]
24. Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major.
Mbow ML; Bleyenberg JA; Hall LR; Titus RG
J Immunol; 1998 Nov; 161(10):5571-7. PubMed ID: 9820534
[TBL] [Abstract][Full Text] [Related]
25. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice.
Biedermann T; Zimmermann S; Himmelrich H; Gumy A; Egeter O; Sakrauski AK; Seegmüller I; Voigt H; Launois P; Levine AD; Wagner H; Heeg K; Louis JA; Röcken M
Nat Immunol; 2001 Nov; 2(11):1054-60. PubMed ID: 11600887
[TBL] [Abstract][Full Text] [Related]
26. The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12.
Himmelrich H; Parra-Lopez C; Tacchini-Cottier F; Louis JA; Launois P
J Immunol; 1998 Dec; 161(11):6156-63. PubMed ID: 9834101
[TBL] [Abstract][Full Text] [Related]
27. Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis.
Stamm LM; Räisänen-Sokolowski A; Okano M; Russell ME; David JR; Satoskar AR
J Immunol; 1998 Dec; 161(11):6180-8. PubMed ID: 9834104
[TBL] [Abstract][Full Text] [Related]
28. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
Iborra S; Carrión J; Anderson C; Alonso C; Sacks D; Soto M
Infect Immun; 2005 Sep; 73(9):5842-52. PubMed ID: 16113303
[TBL] [Abstract][Full Text] [Related]
29. A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice.
Gabaglia CR; Pedersen B; Hitt M; Burdin N; Sercarz EE; Graham FL; Gauldie J; Braciak TA
J Immunol; 1999 Jan; 162(2):753-60. PubMed ID: 9916695
[TBL] [Abstract][Full Text] [Related]
30. Characterization of T cell-mediated responses in nonhealing and healing Leishmania major infections in the absence of endogenous IL-4.
Kropf P; Etges R; Schopf L; Chung C; Sypek J; Müller I
J Immunol; 1997 Oct; 159(7):3434-43. PubMed ID: 9317142
[TBL] [Abstract][Full Text] [Related]
31. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12.
Kohno K; Kataoka J; Ohtsuki T; Suemoto Y; Okamoto I; Usui M; Ikeda M; Kurimoto M
J Immunol; 1997 Feb; 158(4):1541-50. PubMed ID: 9029088
[TBL] [Abstract][Full Text] [Related]
32. Early IL-4 production does not predict susceptibility to Leishmania major.
Scott P; Eaton A; Gause WC; di Zhou X; Hondowicz B
Exp Parasitol; 1996 Nov; 84(2):178-87. PubMed ID: 8932767
[TBL] [Abstract][Full Text] [Related]
33. Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice.
Doherty TM; Coffman RL
Exp Parasitol; 1996 Nov; 84(2):124-35. PubMed ID: 8932762
[TBL] [Abstract][Full Text] [Related]
34. Codelivery of DNA vaccination encoding LeIF gene and IL-12 increases protection against Leishmania major infection in BALB/c mice.
Maspi N; Ghaffarifar F; Sharifi Z; Dalimi A
Parasite Immunol; 2016 Apr; 38(4):228-35. PubMed ID: 26868280
[TBL] [Abstract][Full Text] [Related]
35. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of DNA/DNA and prime-boost vaccination using LPG3 against Leishmania major infection in susceptible BALB/c mice and its antigenic properties in human leishmaniasis.
Abdian N; Gholami E; Zahedifard F; Safaee N; Rafati S
Exp Parasitol; 2011 Mar; 127(3):627-36. PubMed ID: 21187087
[TBL] [Abstract][Full Text] [Related]
37. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
Hugentobler F; Di Roberto RB; Gillard J; Cousineau B
Vaccine; 2012 Aug; 30(39):5726-32. PubMed ID: 22814408
[TBL] [Abstract][Full Text] [Related]
38. Leishmania major-parasitized macrophages augment Th2-type T cell activation.
Chakkalath HR; Titus RG
J Immunol; 1994 Nov; 153(10):4378-87. PubMed ID: 7963516
[TBL] [Abstract][Full Text] [Related]
39. Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis.
Morris L; Troutt AB; Handman E; Kelso A
J Immunol; 1992 Oct; 149(8):2715-21. PubMed ID: 1357029
[TBL] [Abstract][Full Text] [Related]
40. Dissociation of disease susceptibility, inflammation and cytokine profile in lmr1/2 congenic mice infected with Leishmania major.
Elso C; Kumar B; Smyth G; Foote S; Handman E
Genes Immun; 2004 May; 5(3):188-96. PubMed ID: 14762398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]